Collaboration - July 23, 2014
MedImmune teams up with Advaxis
MedImmune has entered into a clinical trial collaboration with Advaxis, Inc., a US-based biotechnology company developing cancer immunotherapies. The two companies will collaborate on a Phase I/II immunotherapy study to evaluate the safety and efficacy of MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Advaxis’ lead cancer immunotherapy vaccine, ADXS-HPV, as a treatment for patients with advanced, recurrent […]
Uncategorized - July 15, 2014
Biotie granted USD 2 million by Michael J. Fox foundation
Finnish biotech company Biotie has received two million dollars from a foundation set up by Hollywood star Michael J. Fox. The grant provides an opportunity to see if Biotie’s SYN120 treatment can slow the progress of dementia in patients with Parkinson’s Disease. The company is now planning a 16-week trial involving 80 patients at about 10 US sites. […]
MedTech Business - July 8, 2014
Bactiguard expands market presence in Southern Africa
The company has entered into exclusive distribution agreements, covering seven sub-Saharan countries. An initial order for Foley catheters has been shipped to Zambia, primarily intended for the University Teaching Hospital in Lusaka (UTH). “We initiated our market activities in Africa just over a year ago and this work is now bearing fruit. We will have a […]
Collaboration - July 4, 2014
Recipharm and Pharmanest collaborate
Recipharm Karlskoga AB and Pharmanest AB form a collaboration for commercial manufacture and supply of SHACT. SHACT is a product based on a formulation of the anesthetic lidocaine and a proprietary application device developed to simplify topical application in the cervix and uterus. It is applied topically in the cervix and uterus with a device developed by Pharmanest. […]
Financing - July 3, 2014
Vaccibody completes NOK 35 million financing
Norwegian company Vaccibody has through a new share issue completed a NOK 35 million financing. The financing comes from both existing and new investors. The largest new investor is represented by Datum and partners, which will take a seat in the Board of Directors. Arctic Securities is the manager for the share issue. According to Vaccibody, […]
Uncategorized - July 3, 2014
Movement disorders in young people related to ADHD
Danish researchers have identified a particular genetic mutation that may cause ADHD and Parkinsonism in young people. In the a study, scientists at the University of Copenhagen and the Copenhagen University Hospital have looked closer at a special protein, the dopamine transporter (DAT). It is a transport protein, which controls the effect of dopamine by mediating re-uptake of released […]
